InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Karin Eastham, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 16 open-market SEC Form 4 transactions: 0 purchases worth $0 and 16 sales worth $148.5M, reported from Aug 2, 21 to Jun 18, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 26 | VCYTVERACYTE, INC. | SELL | 3.2K | $53.55 | $169K |
| Dec 5, 25 | VCYTVERACYTE, INC. | SELL | 12.8K | $46.59 | $587K |
| Nov 5, 25 | VCYTVERACYTE, INC. | SELL | 9.7K | $40.02 | $387K |
| Jun 13, 25 | VCYTVERACYTE, INC. | SELL | 4.6K | $26.66 | $122K |
| Jan 2, 25 | VCYTVERACYTE, INC. | SELL | 5.3K | $40.50 | $213K |
| Nov 19, 24 | VCYTVERACYTE, INC. | SELL | 10.1K | $38.76 | $392K |
| Jul 16, 24 | VCYTVERACYTE, INC. | SELL | 7.5K | $25.00 | $188K |
| Jun 11, 24 | VCYTVERACYTE, INC. | SELL | 3.9K | $20.59 | $80K |
| Jun 7, 24 | VCYTVERACYTE, INC. | SELL | 2.5K | $20.97 | $52K |
| Apr 1, 24 | VCYTVERACYTE, INC. | SELL | 10.0K | $21.65 | $217K |
| Mar 16, 23 | VCYTVERACYTE, INC. | SELL | 18.8K | $22.78 | $427K |
| Feb 28, 23 | VCYTVERACYTE, INC. | SELL | 10.0K | $25.00 | $250K |
| Sep 13, 22 | NKTRNEKTAR THERAPEUTICS | SELL | 21.3K | $3.61 | $77K |
| Dec 17, 21 | VCYTVERACYTE, INC. | SELL | 5.0K | $45.00 | $225K |
| Nov 1, 21 | VCYTVERACYTE, INC. | SELL | 3.0K | $49015.00 | $145.0M |
| Aug 2, 21 | VCYTVERACYTE, INC. | SELL | 2.8K | $44.57 | $124K |